#biontech

[ follow ]

COVID: BioNTech to pay $1.2 billion over vaccine royalties DW 12/28/2024

BioNTech will pay $791.5 million to NIH and $467 million to the University of Pennsylvania regarding COVID-19 vaccine royalty settlements.

'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup | TechCrunch

Instadeep has advanced its AI capabilities significantly while aligning with BioNTech's therapeutic goals post-acquisition.
#lung-cancer

World-first lung cancer vaccine trials launched across seven countries

The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.

Promising lung cancer vaccine trial begins in UK

A new mRNA vaccine for lung cancer could revolutionize treatment by teaching the immune system to target cancer cells specifically.

World-first lung cancer vaccine trials launched across seven countries

The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.

Promising lung cancer vaccine trial begins in UK

A new mRNA vaccine for lung cancer could revolutionize treatment by teaching the immune system to target cancer cells specifically.
morelung-cancer
#mrna-technology

Thousands of cancer patients to trial personalised vaccines

Access to cancer vaccine trials in the NHS for patients using mRNA technology to fight cancer.

Thousands of Patients to Be Given World's First Cancer Vaccine

The NHS is fast-tracking individualized cancer vaccine trials using mRNA technology, starting with various cancer types and expanding the program nationwide.

Thousands of cancer patients to trial personalised vaccines

Access to cancer vaccine trials in the NHS for patients using mRNA technology to fight cancer.

Thousands of Patients to Be Given World's First Cancer Vaccine

The NHS is fast-tracking individualized cancer vaccine trials using mRNA technology, starting with various cancer types and expanding the program nationwide.
moremrna-technology

GSK Says Pfizer Infringed Five Patents Relating to Comirnaty COVID Vaccine

GlaxoSmithKline (GSK) filed a complaint alleging Pfizer and BioNTech's COVID-19 vaccines used GSK's patented inventions, highlighting unacknowledged revolutionary platform application.
[ Load more ]